Tesla (TSLA) deliveries dropped in 2025 as BYD leads in sales volume. Compare both EV giants to find the better investment for your portfolio.
Browsing: Stocks
Circle (CRCL) stock has jumped 115% in 30 days after stellar Q4 results and analyst upgrades. CEO says Wall Street finally understands the business model.
Oklo (OKLO) stock drops as analysts from B. Riley, Needham, and Craig-Hallum cut price targets while insiders sell $170M worth of shares in 90 days.
Elbit Systems (ESLT) stock surges 16% after posting Q4 EPS of $3.52 and achieving first-ever $2B+ revenue quarter with record $28.1B backlog.
Artelo Biosciences (ARTL) stock jumped 40% after announcing a fully-funded glaucoma trial for ART27.13 with Belfast Health and Social Care Trust.
AIM ImmunoTech (AIM) stock soared 97% after Japan’s patent office approved its Ampligen cancer treatment method, valid through December 2039.
Super Micro Computer (SMCI) unveils NVIDIA RTX PRO 4500 Blackwell GPU servers in 1U-5U formats for enterprise AI, edge computing, and data center workloads.
Lumentum (LITE) stock surges 10% after announcing $2B quarterly revenue target and major optical circuit switch win. Stifel maintains $800 price target.
The Trump administration defends Pentagon’s blacklisting of Anthropic in court, citing national security concerns over the AI firm’s safety restrictions.
Nvidia CEO Jensen Huang calls OpenClaw ‘the next ChatGPT’ at GTC, launching NemoClaw. Chinese AI stocks surge 14% while NVDA edges slightly lower.
DocuSign (DOCU) receives price target cuts from Citizens and Wells Fargo amid revenue growth worries, despite Q4 earnings beat and strong IAM performance.
Tesla (TSLA) stock climbed 0.6% after Elon Musk confirmed the March 21 launch of Terafab, a chip factory in Austin designed to meet future AI and robotics demand.
Samsung stock jumped 7.5% after revealing Tesla AI6 chip production plans at Texas plant from H2 2027 and signing AMD HBM4 memory partnership deal.
RBC Capital downgrades Starbucks (SBUX) to Sector Perform, citing higher labor costs and unclear margin path. Stock down 0.9% despite 16% YTD gains.
Gemini (GEMI) stock crashed to new lows after Citi downgraded to Sell with $5.50 target, forecasting $263M loss in 2025 and red ink through 2029.